Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 9Unknown 4Terminated 2Recruiting 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Tumor Surgery 1Polycystic Ovary Syndrome 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Caloric Restriction × Clear all
NCT02792270 2026-05-15

Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

Massachusetts General Hospital

Phase NA Recruiting
32 enrolled

Tumor Surgery

NCT07158723 2025-09-08

Protein and Polycystic Ovary Syndrome (PCOS)

University of Arkansas, Fayetteville

Phase NA Recruiting
60 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡